This is the authors' abstract. We don't add key points for this paper.
Glutaric acidemia (type 1) is an inborn error of metabolism characterized clinically by a progressive extrapyramidal movement disorder in childhood, chemically by the excretion of glutaric and 3-hydroxyglutaric acids in urine, and pathologically by cortical atrophy and progressive neuronal loss and gliosis in the basal ganglia. The disorder is caused by inherited deficiency of glutaryl-CoA dehydrogenase. Some patients with the disorder, even siblings of patients with severe neurologic disease, do not have symptoms. The reason for this is not understood. Similarly, it is not understood why the striatum is so selectively damaged in the disease. The gene that encodes glutaryl-CoA dehydrogenase has been cloned and characterized, and several mutations that cause glutaric acidemia have been defined. However, no one mutation accounts for the majority of mutant alleles found to date.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Goodman et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: